Delivery Order SPE2DB20D3103-SPE2DB23FP4H1
- Not listed
- This federal contract award is for the delivery of Azathioprine 50 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,452.76, was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of November 2, 2023, and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Azathioprine 50 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $2,502.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of May 24, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $1,756.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,915,604 tablets of Azathioprine 50 mg, a medication used to treat various autoimmune disorders. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $12,835.60 from the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of Azathioprine 50 mg tablets, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,561.36 firm fixed-price delivery order is for the supply of 4,560,125,167 units of the pharmaceutical drug Azathioprine 50 mg tablets. The contract has an ultimate completion date of March 3, 2023 and was awarded on March 2, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,557.48 firm-fixed-price delivery order is for the supply of 100 tablets of the drug azathioprine 50 mg. The contract has an ultimate completion date of September 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical...
- This federal contract award is for the delivery of AZATHIOPRINE 50 MG TABLET 100S to the U.S. Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,025.37 and a period of performance through June 10, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,745.84 firm fixed price delivery order is for the supply of Azathioprine 50mg tablets to support military treatment programs and facilities. The award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $2,260.62, is a delivery order for 4,564,222,275 units of the drug Azathioprine 100 mg tablets. The contract has a period of performance through April 10, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $3,598.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of azathioprine 50 mg tablets, a medication used for various medical conditions. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP4H1Delivery Order
This federal contract award is for the delivery of Azathioprine 50 mg tablets to the Defense Logistics Agency (DLA). The $2,862.96 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a child contract under the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. The delivery order supports the procurement of essential medications for federal healthcare facilities, including military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/21/23 |